Alphatec Holdings, Inc. (ATEC)

Alphatec Holdings, Inc. (ATEC) stock has experienced a significant decline over the past six months, falling approximately 61.67%. Key events impacting the stock include a Q1 2026 earnings miss, an adjusted EOS revenue outlook, a shareholder investigation, insider sales, debt refinancing, and analyst coverage adjustments.

Information specifically detailing the demand seasonality for Alphatec Holdings, Inc.'s products and services is not explicitly available in the provided search results. The company's Q1 2026 earnings call mentioned entering "deformity season," where cases tend to be longer and involve higher biologics utilization, suggesting some awareness of seasonal variations in surgical procedures.

Alphatec Holdings, Inc. (ATEC) is a medical technology company focused on designing, developing, and advancing innovative solutions for spinal disorders, operating within the Health Technology sector. The company's products address spinal pathologies like degenerative disc disease, scoliosis, and trauma, including spinal implants like the Arsenal Spinal Fixation System, surgical instruments like the SafeOp Neural InformatiX System, biologics like AlphaGRAFT, and the AIX Product Platform.

Alphatec Holdings, Inc. operates through both United States and International geographical segments. The company has established a significant market presence, particularly in North America and Europe, by fostering strong relationships with spine surgeons and hospitals.

Alphatec Holdings, Inc. aims to be the "Standard Bearer in Spine" through clinical distinction and a data-driven procedural ecosystem. Recent events, such as the Q1 2026 earnings miss and insider sales, could raise concerns among investors. However, the company's surgical business continues to demonstrate strong momentum with volume-driven growth and increasing surgeon adoption.

Alphatec Holdings, Inc. has a significant portion of its stock owned by institutional and individual investors. As of May 4, 2026, institutional owners held approximately 78.79% of the company. Insider ownership is reported to be around 14.96%.